Page last updated: 2024-08-22

camptothecin and Fatty Liver, Nonalcoholic

camptothecin has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almeida, PRC; Lima-Júnior, RCP; Malveira, LRC; Marcolino Assis-Júnior, E; Melo, AT; Moreira, LS; Oliveira, CMG; Pereira, VBM; Sousa, NRP; Souza, MHLP; Wong, DVT1

Other Studies

1 other study(ies) available for camptothecin and Fatty Liver, Nonalcoholic

ArticleYear
Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan.
    Toxicology and applied pharmacology, 2017, 07-15, Volume: 327

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Bacterial Infections; Biomarkers; Camptothecin; Cytokines; Female; Irinotecan; Lipid Metabolism; Liver; Liver Function Tests; Mice; Neutrophil Infiltration; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Silymarin; Sulfhydryl Compounds

2017